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BACKGROUND: Optimal cerebral perfusion pressure (CPPopt) targeting in traumatic brain 
injury (TBI) patients constitutes an active and controversial area of research. It has been 
suggested that an autoregulation guided CPP therapy may improve TBI outcome. 
Prerequisites of a CPPopt intervention study would be objective criteria for the CPPopt 
detection.. This study compared the agreement between automated and visual CPPopt 
detection.   
METHODS: Twenty-five clinicians from 18 centres worldwide, familiar with brain monitoring 
and using dedicated software, reviewed ten 4-hour CPPopt screenshots at 48 hrs after ictus 
in selected TBI patients. Each screenshot displayed the trends of cerebral perfusion pressure 
(CPP), intracranial pressure (ICP), cerebrovascular pressure reactivity (PRx) as well as the 
‘CPP-optimal’ curve and its associated value (automated CPPopt). The main objective was to 
evaluate the agreement between expert clinicians as well as the agreement between the  
clinicians and automated CPPopt. 
RESULTS: Twenty-two clinicians responded to our call (88%). Three screenshots were judged 
as ‘CPPopt not determinable’ by > 45% of the clinicians. For the whole group, the consensus 
between automated CPPopt and clinicians’ visual CPPopt was high. Three clinicians were 
identified as outliers. All clinicians recommended to modify CPP when patients differed > ± 5 
mmHg from their CPPopt. The inter-observer consensus was highest in cases with current 
CPP below the optimal value. 
CONCLUSIONS: The overall agreement between automated CPPopt and visual CPPopt 
identified by autoregulation experts  was high, except for those cases when the curve was 




Optimal cerebral perfusion pressure (CPPopt) targeting in patients with traumatic brain 
injury (TBI) constitutes an active and controversial area of research that still awaits level I 
evidence.(1) The notion of CPP-targeted therapy should be framed in the context of cerebral 
autoregulation—the uninjured brain’s response to variations in cerebral perfusion pressure 
(CPP) through the physiologic relationships between CPP, cerebral blood flow (CBF), and 
vascular resistance. In healthy individuals CBF is adjusted by means of vasodilatation and 
vasoconstriction of cerebral vessels, a process responsible for pressure cerebral 
autoregulation.(2) After severe TBI, cerebral autoregulation is frequently disturbed with CBF 
becoming to some extent dependent on cerebral CPP.(3) International TBI guidelines 
recommend keeping CPP between 60 and 70 mmHg during the whole intensive care unit 
(ICU) admission.(4) It is increasingly felt that CPP management in TBI should be carefully 
individualized to the patient to maximize benefit and minimize harmful side effects of 
unnecessary or inappropriate interventions.(5), (6) However, exactly on what basis this 
should be done is a matter of debate. It is plausible that targeting a CPP where 
autoregulation is best preserved may be one possible strategy that clinicians might use when 
balancing the dangers of hypo or hyperperfusion in a disease that is fundamentally 
heterogeneous.(7)  
Cerebrovascular pressure reactivity is a simple method of assessing globally averaged 
cerebral autoregulation. For patients with closed head injury, it can be easily inferred from 
the pressure reactivity index, PRx (figure 1).(8)  
Negative PRx values reflect a reduction in ICP in response to an increase in MAP indicating 
intact vascular pressure reactivity, whereas positive values, conversely, indicate impairment. 
Due to the fact that it can be determined from periodic variations in ICP and MAP without 
needing external stimuli, the PRx has become widely accepted as a marker for cerebral 
autoregulatory status in many neurocritical care settings.(5) Plotting PRx against CPP will 
often generate a “U” shaped curve, the minimum of which represents the CPP (CPPopt) 
corresponding to the smallest value of PRx where the cerebral autoregulation response is 
most active (figure 1). CPPs both above and below CPPopt are associated with worsened 
cerebrovascular reactivity and with worse outcome.(7;9)  
The 2014 neuromonitoring guidelines promote the concept of autoregulation based 
monitoring and treatments.(5) To this end curve fitting software and heuristics have been 
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developed so that the CPPopt can be automatically calculated and displayed bedside (figure 
2).(10) Whilst observational data is encouraging, a prospective randomised evaluation of 
CPPopt-targeted therapy is urgently required to determine whether CPPopt is purely 
prognostic, or if CPPopt represents a true physiologic target that, if achieved, will improve 
patient outcomes. 
However it is well known that CPPopt curves may be noisy and, in some cases, absent or only 
partially present meaning that a degree of physician assessment and interpretation of the 
autoregulation data is necessary. Before a prospective CPPopt guided intervention study 
could be set up , it is a crucial first step to assess the reliability and (face) validity of 
automated CPPopt calculation and display. If this is not the case, then large inter-rater 
variability means that CPPopt guided therapy is physician dependent and therefore a 
prospective intervention study will fail on its clinical feasibility.  
In this survey the primary objective was to test the agreement between the automatically 
generated CPPopt values (automated CPPopt) and the values deduced from inspection the 
CPPopt curve by clinicians with expertise interpreting CPPopt and PRx (clinicians’ visual 
CPPopt). If clinicians with experience cannot agree then CPPopt  guided therapy cannot 
realistically be deployed at the bedside. We aimed to identify factors that might be 
associated with disagreement. Furthermore, a CPPopt based treatment algorithm currently 
does not exist and as a secondary objective it is important to explore how clinicians would 
adapt therapy if a patient’s current CPP deviates from CPPopt. 
METHODS 
Participants In this cross-sectional survey, 25 intensivists, neurologists and neurosurgeons in 
18 different centres were contacted by email in April 2014. They were all familiar with the 
CPPopt and PRx concept and/or have been publishing in the field of autoregulation research. 
No special training or documentation was offered related to the interpretation or future use 
of the CPPopt methodology.  
Survey All participants were sent a questionnaire that consisted of an introduction, 20 
screenshots of 10 selected TBI patients with for every patient two screenshots, a 48 hour 
monitoring overview and a 4 hour monitoring screenshot 48 hours after trauma ictus. The 
latter was the screenshot of interest (figure 2) and the participants were asked to study this 
screenshot in depth and answer two sets of questions (table 1).  
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Overview screenshot In the introduction of the questionnaire we provided an explanation of 
the structure of the survey and the displayed physiological  variables.. We started with an 48 
hour overview of the ICP/CPP monitoring trends and a CPPopt curve covering the 48 hour 
(CPPopt 48 hours) period. In this overview the exact timing of the 4 hour monitoring 
screenshot was displayed. The reason for this was that in case a CPPopt curve was not 
present at the 48 hour time point, we moved one hour forward till the first 4 hour CPPopt 
curve would appear.  
4 hour screenshot The following physiological variables were displayed in the 4 hour CPPopt 
screenshot: 1-minute values of ICP/MAP/CPP, trends of median CPP and CPPopt, PRx colour 
bar (with dichotomization of PRx into intact (green, PRx <0.3) or impaired (red, PRx>0.3) 
cerebrovascular pressure reactivity simplifying autoregulation status over time),(11) the 
CPPopt curve (PRx error bar versus 5 mmHg CPP intervals plot with the CPPopt fitted curve 
and automated CPPopt value), and a histogram showing the distribution of time spent in the 
different 5 mmHg CPP intervals (figure 2). The PRx error bar represents the median ± 
precision of PRx values in a 5 mmHg CPP interval using 4 hours of monitoring data. PRx is 
calculated as a moving correlation coefficient composed of repeated statistical Pearson 
correlations between mean arterial (blood) pressure (MAP) and intracranial pressure (ICP). 
The method incorporates the philosophy of assessing active cerebrovascular reactions by 
observing the response of cerebral blood volume and subsequent ICP to slow spontaneous 
changes in MAP.(12) Whilst PRx is not a perfect measure of autoregulatory capacity and 
does not reflect focal variations, it has the great advantage of being available in near real-
time. 
Patients The screenshots were taken from 10 selected TBI patients admitted at the 
University Medical Center Groningen  (the Netherlands) during the period 2012 to 2014. In 
this period 35 TBI patients with ICP monitoring were admitted and monitored. All patients 
had ICP monitoring and treatment according to international TBI monitoring 
guidelines.(13;14) ICP/CPP had to be recorded for at least three days for selection for this 
study. No demographic, clinical or diagnostic information were provided. The local medical 
ethical committee waived consent for the anonymized data collection and retrospective data 




Questions For each 4 hour screenshot the clinicians were asked1) either to identify the 
CPPopt visually  (clinicians’ visual CPPopt) or to indicate whether CPPopt is  undeterminable, 
2) to decide which CPP out of four options they would target within the next hours when 
faced with the current patients’ CPP (table 1).  
 
Statistical analysis 
Level of CPPopt agreement The difference between the clinicians’ visual CPPopt (question 
one) and the automated CPPopt was calculated and averaged per screenshot and per 
clinician and presented as the mean ± standard deviation (SD) with 95%-confidence intervals 
(95%-CI). We hypothesized that the group average would be close to zero with small 95%-CI 
intervals. Only cases with a clinicians’ visual CPPopt were used in these calculations. In 
addition, the calculated differences were categorized (%) in four groups: 1) CPPopt not 
determinable. 2) no difference (0 mmHg). 3) difference within the range of ± 5 mmHg. 4) 
difference ≤ -5 or  ≥ 5 mmHg (table 1). An outlier in the last group was identified after 
redefining individual responses by a Z-score  > 3.29 in Statistical Package of Social Sciences 
(SPSS).   
Near future CPP targets From the clinicians who identified CPPopt, the deviation between 
the clinicians’ visual CPPopt value and the current patients’ CPP (question two) was 
calculated and called ‘CPP_difference’. The four treatment options (from question two) were 
reclassified into: 1) ‘Do nothing’. 2)‘Increase CPP’. 3) ‘Decrease CPP’ (table 1). The treatment 
option ‘Reach for the automated CPPopt’ was changed to ‘Increase CPP’ when the 
CPP_difference was negative (theoretically ‘hypoperfusion’) and to ‘Decrease CPP’ when the 
CPP_difference was positive (theoretically  ‘hyperperfusion’). A one-way analysis of variance 
(ANOVA) test was used to compare the mean CPP_difference values for the three CPP 
therapy options. In addition, the CPP_difference variable was divided into seven 5 mmHg 
categories, whereby the distribution of CPP therapy options was analysed. A p-value <0.05 
was considered as statistically significant. Statistical analysis were computed in SPSS, version 
21.   
RESULTS 
Twenty-two clinicians returned the questionnaire (response rate 88%, online supplementary 
material table S1). 96% of the two questions were completely answered and could be used 
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for analysis. Missing data were mainly due to the fact that by mistake clinicians used the 48 
hour monitoring overview (CPPopt 48 hours) instead of 4 hour screenshot(CPPopt).  
Question 1 Agreement with automated CPPopt From the 219 returned answers (only one 
missing), 157 (72%) were answered with a CPPopt value and 62 (28%) were answered with 
CPPopt ‘not determinable’. Figure 3 shows the distribution between automated CPPopt and 
clinicians’ visual CPPopt. From these 157 clinicians’ answers, seventy-two (46%) completely 
agreed with the automated CPPopt value. In seventy-six answers (48%) they agreed within a 
range of ± 5 mmHg. In only nine answers (6%) the clinicians’ visual CPPopt differed > ± 5 
mmHg from the automated CPPopt. Figure 4 shows the difference between the automated 
and clinicians’ CPPopt per screenshot (figure 4a) and per clinician (figure 4b). For the whole 
group the mean calculated difference between automated and clinicians’ visual CPPopt was 
0.01 mmHg (95%-CI: -031 to 0.33, n=157) ( online supplementary material, table S2 and S3). 
The mean value of absolute difference between automated and clinicians’ visual CPPopt was 
0.99 mmHg (95%-CI: 0.72-1.28, n=157).   
Outliers Four answers (of three clinicians) were classified as outliers. They were contacted by 
email. One clinician replied to have chosen the CPP value on the descending part of the 
autoregulation curve whereby PRx was getting negative and not going for the CPP with the 
most negative PRx covered by the curve. Another replied that the present CPPopt curve was 
not convincing and therefore a (higher) CPP was chosen with a lower PRx value (referring to 
the ‘best’ autoregulation condition).  
CPPopt not determinable  In three screenshots > 45% of the clinicians indicated that CPPopt 
was ‘not determinable’ (screenshot 5, 8 and 10; figure 5). By comparing these screenshots 
with the other seven, these less reliable automated CPPopt curves had asymmetrical U-
shaped curves, not covering both positive and negative PRx values, only covering a limited 
range of CPP intervals, or more than one curve could be fitted visually (figure 2B). 
Screenshots with a  CPPopt that were judged 100% determinable were well-covered by the 
available 5 mmHg CPP intervals, covering both positive and negative PRx values and were 
symmetrical U-shaped (figure 2A).  
Question 2 Therapy choices based on differences between current CPP and clinicians’ visual 
CPPopt  For the three CPP therapy options the mean CPP_difference was significantly 
different: 0.6 mmHg (SD 3.6) for option ‘Do nothing’, 6.9 mmHg (SD 4.2) for option ‘Decrease 
CPP’, and -11.0 mmHg (SD 3.8) for option ‘Increase CPP’ (ANOVA F: 206, p < 0.001). To find 
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out at which value clinicians decide to change their CPP therapy, the CPP_difference was 
divided in seven categories and compared per CPP therapy option ( online supplementary 
material, table S4). The main decision (> 90%) is to ‘Do nothing’ with the difference being 
between 5 to -5 mmHg. CPP would be increased by 83% of clinicians with CPP_difference 
being between -5 and -10 mmHg. With an even bigger difference, more than 90% of 
clinicians decided to increase CPP. With a CPP_difference between +5 to +10 mmHg, there is 
less consensus about the CPP policy: 60% indicates not to change CPP and 40% decided to 
decrease CPP.  
DISCUSSION 
The CPPopt concept is a promising ‘biological plausible’ target that uses cerebrovascular 
pressure reactivity to guide individual CPP therapy in severe TBI patients. CPPopt needs to 
be evaluated urgently in prospective intervention studies before recommendations can be 
made as to how, or indeed if, it should be integrated into clinical decision making.(15)  
In this survey we showed a high level of agreement between the choices of a selected 
international group of clinicians and the automated CPPopt value. The approached clinicians 
were selected from a sub-pool of individuals who are familiar with PRx and/or CPPopt 
monitoring. It therefore would seem an essential first step to ensure that the technique is 
reproducible amongst “experts” before even contemplating rolling it out further. Any 
subsequent intervention study would similarly be attempted in a small group of ‘expert’ 
ICUs.  
Overall rating of face validity of automated CPPopt  (question 1) The overall agreement 
between the automated CPPopt and visual judgement was excellent when the PRx-CPP 
relationship followed a reasonably well defined U shape curve. However, in 3 screenshots a 
large percentage of clinicians found the fitted CPPopt curve not reliable enough to retrieve a 
convincing CPPopt. In addition, four answers (from 3 clinicians) could be labelled as outliers. 
In-depth examination of these results revealed important clues for clinicians doubting the 
automated CPPopt value. As it appeared, the visual CPPopt detection of a curve is found less 
reliable if the underlying PRx-CPP relationship is asymmetrical , does not cover both positive 
and negative PRx values, only covers a limited CPP range, and if more than one curve can be 
fitted visually (figure 2B). Currently we are working on improving the automated CPPopt 
algorithm by  incorporation of multiple-(time) window calculations with the hypothesis that 
it improves the continuity and stability of CPPopt significantly.(16;17) In addition we are 
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evaluating the influence of CPPopt calculation weighting factors like time, PRx-CPP curve 
shape, curve fit errors  and  autoregulation status on automated (multi-window) algorithm 
performance.   
CPP guided therapy  (question 2) Most clinicians decided to change CPP in the direction of 
their selected CPPopt when the absolute difference between the patients’ current CPP and 
clinicians’ visual CPPopt was > 5 mmHg whereby CPP below optimal reaches very high 
consensus for therapy change. CPP above optimal leads to a more variable decision. For the 
set-up of a CPPopt feasibility study, the current ICP/CPP oriented treatment algorithm 
should be adapted with individual CPPopt targets replacing the current 60-70 mmHg CPP 
guideline range. Also in other brain pathologies an individual and up-to-date cerebral 
perfusion target is probably of benefit during intensive care admission. The results of this 
study might help with the set-up of other ‘optimal’ targeted therapy intervention study 
initiatives in acute stroke, neonatology and post-cardiac arrest patients.(18-20)  
Limitations The 22 clinicians are all active in autoregulation research and are all familiar with 
the CPPopt method. The selection was chosen as a pragmatic one but therefore not an 
exclusive list of world-wide expertise. Furthermore we cannot be sure from our result that 
this will generalize to ‘non-expert’ practice. But expert consensus/ reproducibility is a pre-
requisite for such generalizability. With the screenshots, only limited physiological 
information, no clinical results and limited answer options were provided. More specific and 
complete (lengthy) screenshots or clinical scenarios with open answers might have yielded 
different responses but probably decreased the survey response rate, increased the 
heterogeneity of the answers and distracted from the main objective of this study.  
Questionnaire validity It is difficult to validate a (relatively) small scale questionnaire and we 
did not attempt to do so formally. Face-validity of our survey was, however, assured by 
consensus between the authors. It is also important to stress the fact that no golden 
standard is present for cerebral autoregulation or CPPopt related results.   
Future studies With the results of this survey we think we have made an essential step 
towards further design of the first CPPopt feasibility study, which will be an entry point 
towards a proper randomized ‘CPPopt targeted’ versus ‘current standard treatment’ TBI 
intervention trial. Even with a positive outcome we would not support a final strategy of just 
treating an individual number, like CPPopt, rather than the whole patient, particularly in the 
context of severe TBI. Such approaches to intensive care have failed historically. (14;21;22) 
11 
 
At the moment we can only conclude that for planned intervention studies both the 
automated value and the PRx-CPP plot (figure 2) should be available for testing of CPPopt 
guided management at the bedside to yield a trustworthy CPPopt.         
 
CONCLUSIONS The overall agreement between the automated CPPopt value and the value 
identified by autoregulation experts clinicians was high, except for those cases when the 
fitted curve was deemed by clinicians not reliable enough to yield a trustworthy CPPopt. 
Possible solutions like automated weighting and (multiple) averaging are currently under 
investigation. When CPPopt deviated more than 5 mmHg from the current patients’ CPP, the 
majority of clinicians opted to change therapy. Any benefit of CPPopt guided therapy or 





 Autoregulation guided cerebral perfusion pressure (CPPopt) therapy in TBI patients 
constitutes an active and controversial area of research 
 
 Prerequisites of a CPPopt intervention study would be objective criteria for the 
CPPopt detection (automated CPPopt display) at the bedside 
 
 The overall agreement between the automated CPPopt value and the visual CPPopt 
value identified by autoregulation experts was high, except for those cases when the 
fitted curve was deemed not reliable enough to yield a trustworthy CPPopt 
 
 Any benefit of CPPopt guided therapy or other more sophisticated CPP based 
treatments needs to be proven in prospective studies with incorporation of 





Figure 1 Schematic depicting the theoretical relationship between CPP and PRx including 
estimation of CPPopt 
 
Figure 2A Example of 4 hour monitoring screenshot used in the survey 
 
Figure 2B Example of 4 hour monitoring screenshot used in the survey  
 
 
Figure 3 Distribution of automated CPPopt and clinicians’ visual CPPopt (scatterplot)  
 
Figure 4A Mean difference between automated CPPopt and clinicians’ visual CPPopt 
calculated per 4 hour screenshot 
 
Figure 4B Mean difference between automated CPPopt and clinicians’ visual CPPopt 
calculated per clinician 
 
Figure 5 Number of clinicians appointing a CPPopt value or ‘CPPopt not determinable’ for 














Figure 1 The relationship between CPP and PRx can be approximated by fitting an U-shaped 
curve (2nd order polynomial mathematical function) automatically whereby with both high or 
low values of CPP, the cerebral pressure reactivity (PRx) is impaired (top right panel, red). 
However, for intermediate CPP values, PRx is (probably) working (bottom right panel, green) 
and the CPP at which PRx is most negative is termed the ‘optimal’ CPP (CPPopt, black dot). 
Abbreviations: CPP(opt) indicates (optimal) cerebral perfusion pressure, PRx, pressure 
reactivity index. 
Figure 2 A + B Patient cerebral monitoring screenshot representing 4 hours of monitoring. In 
the upper graph the MAP (blue), CPP (yellow) and ICP (white) are shown. The second graph 
shows trends of CPP (yellow) and CPPopt (red). The coloured bar is green when PRx is < 0.3 
and red when PRx is > 0.3, representing working and impaired pressure reactivity 
respectively.(11) Underneath the green bar, the features of the CPPopt curve are shown 
(yellow). This curve is automatically fitted through the mean of the binned PRx error bars.(7) 
CPPopt is the CPP where PRx is at its lowest value, which has a value of 70 and 94 mmHg in 
screenshot A and B, respectively. The bottom graph shows the percent of time that the CPP 
was in each 5 mmHg CPP interval during the 4 hour period.  
Abbreviations: MAP indicates mean arterial (blood) pressure, CPP(opt), (optimal) cerebral 
perfusion pressure, ICP, intracranial pressure, PRx, pressure reactivity index.  
 
Figure 3 Scatterplot of the automated CPPopt versus the clinicians’ visual CPPopt (n=157).  
Abbreviations: CPP(opt) indicates (optimal) cerebral perfusion.  
 
Figure 4 A Mean difference between automated CPPopt and clinicians’ visual CPPopt 
calculated per screenshot. B Mean difference between automated CPPopt and clinicians’ 
visual CPPopt calculated per clinician. Larger (grey) bullets represent mean values. Smaller 
bullets represent individual CPP differences between automated and visual numbers.  




Figure 5 The x-axis shows the 10 patient 4 hour screenshots and the y-axis shows the 
number of clinicians who appointed a CPPopt value (black) or ‘CPPopt not determinable’ 
(grey). Numbers represent the responses of the clinicians. 





Online supplementary materials  
 
Online supplementary material table S1 List of responding participants for the survey. 
 
Online supplementary material table S2  Difference between the individual clinicians’ visual 
CPPopt and automated CPPopt value per screenshot.  
 
Online supplementary material table S3  Difference between the individual clinicians’ visual 
CPPopt and automated CPPopt value per clinician. 
 
Online supplementary material table S4 The different therapy options for the categorized 
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